Harmony Biosciences Holdings (HRMY) Inventory Average (2020 - 2026)
Harmony Biosciences Holdings recorded quarterly Inventory Average of $5.5 million in Q1 2026, down 11.59% quarter-over-quarter from $6.2 million in Q4 2025, and down 20.22% year-over-year from $6.9 million in Q1 2025.
Harmony Biosciences Holdings' Inventory Average history runs 7 years deep, the most recent figure standing at $5.5 million for Q1 2026.
- In Q1 2026, Inventory Average fell 20.22% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $5.5 million (down 20.22% YoY), while the FY2025 annual figure was $6.4 million, up 1.26% from the prior year.
- Inventory Average came in at $5.5 million for Q1 2026 at Harmony Biosciences Holdings, down from $6.2 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $7.1 million in Q4 2024 to a low of $4.2 million in Q1 2023.
- A 5-year average of $5.5 million and a median of $5.5 million in 2026 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average soared 33.78% in 2024 and declined 20.22% in 2026, its largest moves.
- Harmony Biosciences Holdings' Inventory Average stood at $4.4 million in 2022, then climbed by 21.47% to $5.4 million in 2023, then soared by 31.42% to $7.1 million in 2024, then slipped by 12.12% to $6.2 million in 2025, then slipped by 11.59% to $5.5 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $5.5 million, $6.2 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | 5.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.48 Mn |
| Dec 31, 2025 | 6.20 Mn |
| Sep 30, 2025 | 6.57 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 7.06 Mn |
| Sep 30, 2024 | 6.28 Mn |
| Jun 30, 2024 | 5.75 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Dec 31, 2023 | 5.37 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 4.62 Mn |
| Mar 31, 2023 | 4.19 Mn |
| Dec 31, 2022 | 4.42 Mn |
| Sep 30, 2022 | 4.60 Mn |
| Jun 30, 2022 | 4.85 Mn |
| Mar 31, 2022 | 4.74 Mn |
| Dec 31, 2021 | 4.84 Mn |
| Sep 30, 2021 | 5.10 Mn |
| Jun 30, 2021 | 4.83 Mn |
| Mar 31, 2021 | 4.27 Mn |
| Dec 31, 2020 | 3.09 Mn |